Your browser doesn't support javascript.
loading
The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.
Slater, Hannah C; Ross, Amanda; Felger, Ingrid; Hofmann, Natalie E; Robinson, Leanne; Cook, Jackie; Gonçalves, Bronner P; Björkman, Anders; Ouedraogo, Andre Lin; Morris, Ulrika; Msellem, Mwinyi; Koepfli, Cristian; Mueller, Ivo; Tadesse, Fitsum; Gadisa, Endalamaw; Das, Smita; Domingo, Gonzalo; Kapulu, Melissa; Midega, Janet; Owusu-Agyei, Seth; Nabet, Cécile; Piarroux, Renaud; Doumbo, Ogobara; Doumbo, Safiatou Niare; Koram, Kwadwo; Lucchi, Naomi; Udhayakumar, Venkatachalam; Mosha, Jacklin; Tiono, Alfred; Chandramohan, Daniel; Gosling, Roly; Mwingira, Felista; Sauerwein, Robert; Paul, Richard; Riley, Eleanor M; White, Nicholas J; Nosten, Francois; Imwong, Mallika; Bousema, Teun; Drakeley, Chris; Okell, Lucy C.
Afiliación
  • Slater HC; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, W2 1PG, UK. hslater@path.org.
  • Ross A; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, 4002, Switzerland.
  • Felger I; University of Basel, Basel, 4001, Switzerland.
  • Hofmann NE; University of Basel, Basel, 4001, Switzerland.
  • Robinson L; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, 4002, Switzerland.
  • Cook J; University of Basel, Basel, 4001, Switzerland.
  • Gonçalves BP; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, 4002, Switzerland.
  • Björkman A; Vector-borne Diseases Unit, Papua New Guinea Institute for Medical Research, Madang, Papua New Guinea.
  • Ouedraogo AL; Division of Population Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, VIC, Australia.
  • Morris U; Medical Biology, University of Melbourne, Melbourne, 3010, VIC, Australia.
  • Msellem M; Disease Elimination, Burnet Institute, Melbourne, 3004, VIC, Australia.
  • Koepfli C; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
  • Mueller I; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
  • Tadesse F; Malaria Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Gadisa E; Département de Sciences Biomédicales, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, 01 BP 2208, Burkina Faso.
  • Das S; Institute for Disease Modeling, Intellectual Ventures, Bellevue, 98005, Washington, USA.
  • Domingo G; Malaria Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Kapulu M; Department of Training and Research, Mnazi Mmoja Hospital, Zanzibar, Tanzania.
  • Midega J; Population Health and Immunity Division, Walter and Eliza Hall Institute, Melbourne, 3052, Victoria, Australia.
  • Owusu-Agyei S; Department of Biological Sciences, University of Notre Dame, Indiana, 46556, USA.
  • Nabet C; Division of Population Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, VIC, Australia.
  • Piarroux R; Department of Parasites and Insect Vectors, Institut Pasteur, Paris, 75015, France.
  • Doumbo O; Medical Biology, University of Melbourne, Melbourne, 3010, VIC, Australia.
  • Doumbo SN; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, 6525, The Netherlands.
  • Koram K; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Lucchi N; Institute of Biotechnology, Addis Ababa University, Addis Ababa, Ethiopia.
  • Udhayakumar V; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Mosha J; Diagnostics Program, PATH, Seattle, Washington, 98121, United States of America.
  • Tiono A; Diagnostics Program, PATH, Seattle, Washington, 98121, United States of America.
  • Chandramohan D; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
  • Gosling R; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya, Centre for Genomics and Global Health, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Mwingira F; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
  • Sauerwein R; KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya, Centre for Genomics and Global Health, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Paul R; Institute of Health, University of Health and Allied Sciences, Hohoe, PMB 31, Ghana.
  • Riley EM; Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP- HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie-Mycologie, Paris, 75646, France.
  • White NJ; Sorbonne Université, INSERM, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP- HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie-Mycologie, Paris, 75646, France.
  • Nosten F; Malaria Research and Training Centre, Parasitic Diseases Epidemiology Department, UMI 3189, University of Sciences, Technique and Technology, Bamako, Mali.
  • Imwong M; Malaria Research and Training Centre, Parasitic Diseases Epidemiology Department, UMI 3189, University of Sciences, Technique and Technology, Bamako, Mali.
  • Bousema T; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
  • Drakeley C; Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Global Health, Centers for Disease Control and Prevention, Atlanta, 30030, GA, United States of America.
  • Okell LC; Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Global Health, Centers for Disease Control and Prevention, Atlanta, 30030, GA, United States of America.
Nat Commun ; 10(1): 1433, 2019 03 29.
Article en En | MEDLINE | ID: mdl-30926893
ABSTRACT
Malaria infections occurring below the limit of detection of standard diagnostics are common in all endemic settings. However, key questions remain surrounding their contribution to sustaining transmission and whether they need to be detected and targeted to achieve malaria elimination. In this study we analyse a range of malaria datasets to quantify the density, detectability, course of infection and infectiousness of subpatent infections. Asymptomatically infected individuals have lower parasite densities on average in low transmission settings compared to individuals in higher transmission settings. In cohort studies, subpatent infections are found to be predictive of future periods of patent infection and in membrane feeding studies, individuals infected with subpatent asexual parasite densities are found to be approximately a third as infectious to mosquitoes as individuals with patent (asexual parasite) infection. These results indicate that subpatent infections contribute to the infectious reservoir, may be long lasting, and require more sensitive diagnostics to detect them in lower transmission settings.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Parásitos / Plasmodium falciparum / Malaria Falciparum Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Parásitos / Plasmodium falciparum / Malaria Falciparum Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article